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Abstract
Background: Edible mushrooms, especially the genus of Pleurotus, have been well studied for their nutrition as
well as non-toxic medicinal properties. Recently, much attention has been paid to the therapeutic values of
mushrooms in genus of Pleurotus with diabetes mellitus (DM), which was a complex metabolic disorder that
induced by increased oxidative stress and characterized by hyperglycemia. However, scare attention has been paid
to polysaccharides from P. djamor. Meanwhile, zinc is an essential trace element in the human body and it
participates in various pathways of metabolism. Therefore, the objective of present study was aimed to evaluate the
protective effects of the three extractable mycelium zinc polysaccharides (MZPS), including acidic-MZPS (Ac-MZPS),
alkalic-MZPS (Al-MZPS) and enzymatic-MZPS (En-MZPS), on the liver and kidneys in diabetic mice induced by
streptozocin (STZ) aiming to better understand the possible hypoglycemic mechanisms and their health benefits.
Methods: The Ac-, Al-, and En-MZPS were extracted with hydrochloric acid (1 M), sodium hydroxide (1 M) and
snailase (4 %) from P. djamor zinc-enriched mycelium, respectively. The diabetic mice were induced by injection of
STZ. Besides the histopathological analyses of liver and kidney, the following biochemical analysis were processed
to investigate the antioxidative effects, including activities of superoxide dismutase (SOD), GSH peroxide (GSH-Px)
and catalase (CAT), and contents of malondialdehyde (MDA) in liver and kidney homogenate; activities of alamine
aminotransferase (ALT) and aspertate aminotransferase (AST), and levels of urea nitrogen (BUN), creatinine (CRE),
total cholesterol (TC), albumin (ALB), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein choles-
terol (LDL-C) and very low-density lipoprotein cholesterol (VLDL-C) in serum.
Results: Results showed that the activities of SOD, GSH-Px and CAT were significantly increased, the MDA contents
remarkably reduced, and the values of ALT, AST, BUN, CRE, TC, LDL-C and HDL-C observably mitigated in the liver,
kidneys and serum of diabetic mice by these three polysaccharides treatment. Biochemical and histopathological
analyses also showed that MZPS could alleviate liver and kidneys injury.
Conclusion: These results demonstrated that Ac-, Al-, and En-MZPS possessed potent antioxidant activities, and
could be used as a potentially functional food for the prevention of diabetes and its complications induced by STZ.
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Background
Nowadays, mushrooms have become attractive not only
due to their excellent taste, but also thanks to their
healthy properties [1]. Mushrooms have been tradition-
ally used in medicine as a source of new drugs due to
the occurrence of a wide number of bioactive com-
pounds involved in the prevention and treatment of sev-
eral diseases, such as cancer, inflammatory disease,
heperlipidemia, diabetes, and liver damage [2]. Among
the most important metabolites obtained from mush-
rooms, polysaccharides have gained much attention
owing to their demonstrated bioactivities, such as ability
of scavenging the free radicals, anti-tumor [3], immuno-
regulation [4], antioxidant [5], anti-aging [6], anti-
diabetic [7] and hepatoprotective effects [8]. In addition,
a concerted effort to improve the nutrition with polysac-
charides supplementation has been ongoing in the bio-
availability areas.
In recent years, increasing evidence in both experi-
mental and clinical studies have pointed out that in-
creased oxidative stress, accompanied by increased
production of reactive oxygen species (ROS) or impaired
antioxidant defenses, is a widely accepted participant in
the development, progression and pathogenesis of dia-
betes and its complications, such as diabetes mellitus
(DM) [9–13]. DM is a complex metabolic disorder char-
acterized by hyperglycemia due to the improper
utilization of glucose [14]. According to the statistics
from the International Diabetes Federation (IDF, 2012),
more than 371 million people are diagnosed to have dia-
betes and the number of people with DM are rising ex-
ponentially. Undoubtedly, the DM has been regarded as
one of the greatest medical and socioeconomic chal-
lenges worldwide [15]. However, mechanisms by which
increased oxidative stress is involved in the diabetic
complications are not well defined. Many factors includ-
ing viral infection, autoimmune disease, unnormal diet
and environmental factors have potential in raising the
risk of DM. Streptozotocin (STZ), an antibiotic pro-
duced by Streptomyces achromogenes, is frequently used
to induce DM in experimental animals due to its toxic
effects on generation of ROS causing oxidative damage
on the liver and kidney for evaluating the therapeutic
potential of antidiabetics [16]. Evidence is accumulating
which indicates that the hpyerglycemic-related activities
of polysaccharides may be linked to their known antioxi-
dant and pre-oxidant properties, suggesting that mush-
room polysaccharides have promising activity for the
prevention of diabetes. Therefore, there is a strong need
for safe and effective oral anti-hyperglycaemic agents
that provide an alternative option for preventing, and
treating diabetes and its complications.
It has been reported that polysaccharides isolated from
the genus of Pleurotus showed many biological activities.
Documents has been reported that some species in the
genus of Pleurotus, such as P. eryngii [17], P. ostreatus
[18], P. Tuber-regium [19], and P. cystidiosus [20] etc.,
showed potential effects in treatment with DM. In this
regard, the polysaccharides extracted from P. djamor, a
new species classifies in the genus of Pleurotus that ap-
preciated as an edible and medicinal mushrooms in
China, may play a promising role in the treatment with
liver and kidney damage that induced by hyperglycemia.
However, to our best knowledge, so far there is scare
publication information about the antioxidant effects of
polysaccharides extract from mycelium of P. djamor, and
there are no available studies regarding the role of ROS
in STZ-induced liver and kidney damage. Meanwhile,
zinc is an essential trace element in the human body and
it participates in various pathways of metabolism [21].
Interestingly, it has been proved by our previous report
that, after submerged fermentation with zinc-compound
(zinc acetate), zinc-enriched polysaccharides is shown to
exhibit significantly higher bioactivities than regular
polysaccharides (The work of enrichment of zinc and P.
djamor has been processed, but the data were not shown
here) [22]. Urgently, it is quite necessary and significa-
tive to explore polysaccharides from the zinc-enriched
mycelia of P. djamor and evaluate their protective effects
against DM.
The objective of present study was conducted to
evaluate the protective effects of the three extractable
mycelium zinc polysaccharides (MZPS), including
acidic-MZPS (Ac-MZPS), alkalic-MZPS (Al-MZPS) and
enzymatic-MZPS (En-MZPS), on the liver and kidneys
in diabetic mice induced by STZ-injection in order to
better understand the possible hypoglycemic mecha-
nisms and their health benefits.
Methods
Organism and chemicals
The strain of P. djamor was provided and identified by
Department of Microbiology of Shandong Agricultural
University (Taian, Shandong), and the deposition num-
ber was SAB-01. The diagnostic kits of superoxide dis-
mutase (SOD), glutathione peroxidase (GSH-Px),
catalase (CAT), and malondialdehyde (MDA) were pur-
chased from Nanjing Jiancheng Bioengineering Institute
(Nanjing, China). Snailase and streptozocin (STZ) was
purchased from Sigma Chemicals Company (St. Louis,
USA). All other chemicals were of analytical grade and
purchased from local chemical suppliers.
Preparation of Ac-, Al-, and En-MZPS
The liquid fermentation technology was used to produce
MZPS by P. djamor. Each 250-mL flask, containing
100 mL basal medium (g/L) of potato 200, glucose 20,
KH2PO4 1.5, MgSO4 · 7H2O 1 and with ZnSO4 (3 g/L,
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3 mL) for supplying the zinc, was kept cultivation at 25 °C
with a shaking of 140 rpm for 10 days. After filtration,
concentration, sterilization and lyophilization, the myce-
lium was extracted with proper volumes of hydrochloric
acid (1 M), sodium hydroxide (1 M) and snailase (4 %) at
35 °C for 4 h (1:4, w/v). The supernatant liquids were pre-
cipitated by ethanol precipitation (1:3, v/v) at 4 °C over-
night, collected by centrifugation and deproteinated by
employing the Sevage method [23], respectively. Finally,
the deproteinated precipitates were pooled and lyophilized
to yield Ac-, Al-, and En-MZPS, which were used for fur-
ther studies.
Animal experiments
The experiments were performed as approved by the in-
stitutional animal care and use committee of Shandong
Agricultural University, and in accordance with the Ani-
mals (Scientific Procedures) Act. 1986 (amended 2013).
Kunming strain mice, weighed 20 ± 2 g (4 weeks old),
was purchased from Taibang Biological Products Ltd.
Co. (Taian, China). The mice were acclimated for 2 days
prior to dosing, during which time they had free access
to food and water ad libitum (temperature 22 ± 1 °C, hu-
midity 60 to 65 %, lights on 12 h every day). For diabetes
induction, mice were fasted overnight and then intraper-
itoneally injected with 120 mg/Kg STZ (freshly dissolved
in sodium citrate buffer (pH 4.5) and immediately
injected within 20 min of preparation) [24–26]. Control
mice (NC groups) were intraperitoneally injected with
citrate buffer alone. Two days after STZ injection, the
diabetic state was assessed by measuring blood glucose
(GLU) levels after fasting overnight. Mice with GLU
levels over 11 mM were considered as successful models
of diabetic. All diabetic mice were randomly divided into
11 groups including model groups (MC), positive groups
(PC), nine dosage groups of three high dosage groups
(800 mg/Kg), three middle dosage groups (400 mg/Kg),
and three low dosage groups (200 mg/Kg). During the
gavage procedure, the NC and MC groups received vehi-
cleonly (distilled water) only, while the dose groups re-
ceived Ac-, Al-, and En-MZPS at dosage of 800, 400,
200 mg/Kg, respectively. The vehicle or test drugs were
suspended in distilled water. The treatment with poly-
saccharides was started 5 days after STZ injection and
was lasted for 2 weeks. At the end of the experimental,
the mice were fasted overnight, and then sacrificed by
exsanguinations under diethyl ether anesthesia.
Serum was obtained from the blood by centrifugation
(14,000 × g, 4 °C). Alamine aminotransferase (ALT) ac-
tivity, aspertate aminotransferase (AST) activity, urea ni-
trogen (BUN) levels, creatinine (CRE) levels, total
cholesterol (TC) levels, albumin (ALB) levels, high-
density lipoprotein cholesterol (HDL-C) levels, low-
density lipoprotein choles-terol (LDL-C) levels and very
low-density lipoprotein cholesterol (VLDL-C) levels of
serum were measured using automatic biochemical
analyzer (ACE, USA).
The liver and kidney index was calculated by (liver
weight)/(body weight) (g/100 g). The atherogenic index
(AI) was calculated as (TC–HDL-C)/HDL-C [27].
The liver and kidney were rapidly removed, weighed
and homogenized (1:9, w/v) immediately in phosphate
buffer solutions (PBS, 0.2 M, pH 7.4). After centrifuga-
tion (5000 × g, 4 °C) for 20 min, the supernatants were
collected for further biochemical analysis. The activities
of SOD, GSH-Px and CAT, and contents of MDA in
liver and kidney homogenates were determined by the
commercial reagent kits according to the instructions.
Liver and kidney cortex samples were immersed in the
PBS buffer containing 10 % formalin (pH 7.4) for over
24 h and embedded in paraffin. Thin sections (4–5 μm
thickness) were prepared by using a microtome and
stained with hematoxylin-eosin. Each section was photo-
graphed under microscope to show the histopathological
changes (×400 magnifications).
Acute toxicity
Acute toxicity test in mice was performed according
to the method of Chao et al. [28]. Male mice were
divided into three dose-groups and one control group
(Ten mice in each group). The dose-groups was
performed by using oral dosages of Ac-, Al-, and
En-MZPS (5000 mg/kg). Control group received the
isometric saline solutions. All mice were allowed for
food ad libitum for 14 days and kept under regular
observation for any mortality or behavioral changes
(irritation, restlessness, respiratory distress, abnormal
locomotion, and catalepsy etc.).
Statistical analysis
All data were presented as the mean ± standard devi-
ation (SD) from three independent experiments. Signifi-
cant differences among the groups were determined by
one-way ANOVA using the IBM SPSS Statistical soft-
ware package program. P < 0.05 was considered to be
statistically significant.
Results
Body weight, blood glucose levels, liver index and kidney
index
The effects of Ac-, Al-, and En-MZPS on GLU levels,
body weight, liver index, and kidney index of STZ-
induced diabetic mice were presented in Fig. 1.
The diabetic mice exhibited a significant increase in GLU
levels as compared to the NC group (Fig. 1A, P < 0.01). The
administration of Ac-, Al-, and En-MZPS at different doses
caused significant decrease in GLU levels in diabetic mice
when compared with untreated diabetic mice (MC group,
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P < 0.01 or P < 0.05). Detailedly, compared with the MC
group, at the end of the experiment, the GLU levels of mice
in Ac-, Al-, and En-MZPS at three doses (800, 400, and
200 mg/Kg) groups were reduced by 34.74 ± 7.57, 57.58 ±
3.15, 37.74 ± 6.36, 42.89 ± 2.77, 14.50 ± 4.51, 30.60 ± 4.12,
62.26 ± 6.21, 46.23 ± 8.32, and 52.37 ± 5.07 %, respectively.
Simultaneously, the body weight of diabetic mice was
also observed. As shown in Fig. 1B, the body weight of
mice in NC group increased regularly during the admin-
istration. However, the diabetic mice in MC group
expressed a significant loss of body weight as compared
to NC group (P < 0.01). Compared with the MC group,
Fig. 1 Effects of Ac-, Al-, and En-MZPS on (A) GLU levels, (B) Body weight, (C) Liver index, and (D) Kidney index in STZ-treated mice. The values
are reported as the mean ± SD of ten mice per group: (a) P < 0.01 and (b) P < 0.05 compared with NC groups; (c) P < 0.01 and (d) P < 0.05 com-
pared with the MC groups
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at the end of the experiment, the body weight of mice in
Ac-, Al-, and En-MZPS at three doses (800, 400, and
200 mg/Kg) groups were increased by 26.68 ± 4.17,
31.59 ± 5.22, 36.51 ± 3.41, 33.59 ± 1.97, 34.56 ± 1.82,
48.85 ± 3.22, 35.07 ± 6.06, 35.28 ± 3.27, and 41.56 ±
2.68 %, respectively (all P < 0.01).
The kidney and liver indexes of mice in all groups
were shown in Figs. 1C and D. Apparently, both signifi-
cant increases could be seen in MC group when com-
pared to the NC group (P < 0.01) in liver and kidney.
However, the increases in liver and kidney could be miti-
gated by pretreatment with Ac-, Al-, and En-MZPS at
three different doses (P < 0.05 or P < 0.01), respectively.
Meanwhile, when tested at a dosage of 400 mg/Kg,
glibenclamide as a standard antioxidant (hyperglycemic
agent) also effectively protected liver and kidney against
the oxidative damage induced by STZ (Fig. 1).
Effects of Ac-, Al-, and En-MZPS on SOD, GSH-Px, CAT,
and MDA
As Fig. 2 displayed, significant reductions in SOD, GSH-
Px and CAT activities, and significant elevations of
MDA contents were observed in STZ-induced diabetic
mice as compared to the NC group (P < 0.01), respect-
ively. In this work, the SOD and GSH-Px activities of
En-MZPS in liver were expressed dose-dependently
(Figs. 2A and B), however, the CAT activities of En-
MZPS were not very dose dependent, at the tested doses
of 800, 400, and 200 mg/Kg (Fig. 2C), respectively. The
SOD and GSH-Px activities reached the maximum of
173.2 ± 14.38 and 93.9 ± 11.24 U/mg prot in the high
dosage of En-MZPS, which were significantly higher
than that in MC group (74 ± 5.56 and 32 ± 5.40 U/mg
prot, both P < 0.01). As for CAT activities, it reached
245.8 ± 19.26 U/mg prot in the low dosage of En-MZPS,
which was higher than that in diabetic control group
(97.5 ± 6.89 U/mg prot) (Fig. 2C). Nevertheless, inverse
tendency of En-MZPS on SOD, GSH-Px, and CAT activ-
ities in kidney were depicted in Figs. 2E, F, and G. As
shown in Fig. 2E, significant attenuations in SOD activ-
ities were observed after the administration of Ac-, Al-
and En-MZPS at three doses of 800, 400, 200 mg/Kg
(41.9 ± 2.12, 61.3 ± 7.57, 85.1 ± 3.97, 71.3 ± 8.58, 89.0 ±
9.13, 64.5 ± 12.40, 65.1 ± 4.98, 69.2 ± 3.85 and 76.1 ± 7.55
U/mg prot, respectively), when compared to diabetic
control group (27.4 ± 8.03 U/mg prot). Similar results
were observed in GSH-Px activities (131.1 ± 9.17, 102.7
± 4.87, 97.5 ± 9.13, 106.9 ± 7.83, 108.5 ± 6.01, 145.3 ±
8.64, 145.6 ± 3.26 and 152.4 ± 4.88 U/mg prot, respect-
ively) (Fig. 2F), and CAT activities (66.1 ± 7.10, 99.4 ±
5.34, 162.8 ± 126.62, 90.3 ± 2.84, 111.5 ± 10.00, 128.0 ±
7.62, 130.4 ± 6.69, 162.8 ± 13.41, and 170.1 ± 15.26 U/mg
prot, respectively) (Fig. 2G). Glibenclamide-treated mice
also manifested significant fall of the SOD, GSH-Px, and
CAT activities in liver and kidney compared to STZ-
treated mice.
As shown in Figs. 2D and H, the contents of MDA
were significantly increased (P < 0.01) in liver and kid-
ney of diabetic mice when compared to NC group.
Obviously, we could conclude that En-MZPS had
strong potential antioxidant effects at high dose
(800 mg/Kg) in liver (Fig. 2D), whereas at low dose
(200 mg/Kg) in kidney (Fig. 2H).
The assays of serum biochemistry
Several enzymes and substances in serum were used as
biochemical markers for early liver and kidney damage,
such as AST and ALT for liver, and BUN, CRE and ALB
for kidney. As displayed in Fig. 3, mice treated with STZ
alone showed liver damage and kidney damage as evi-
denced by significant increase in the serum activities of
AST and ALT, and levels of BUN, CRE and ALB when
compared with NC groups (all with P < 0.01). Interest-
ingly, pretreatment with Ac-, Al- and En-MZPS signifi-
cantly suppressed elevations in these indexes (P < 0.01 or
P < 0.05) compared with MC groups, especially En-
MZPS at the dose of 200 mg/Kg (P < 0.01) (Figs. 3A–E).
The results signified that supplementation with Ac-, Al-
and En-MZPS could depress the activities of AST and
ALT, levels of BUN, CRE and ALB in STZ-intoxicated
mice and appeared to be protective in undermining the
deleterious effects of STZ in liver and kidney.
Figures 3F and G showed that the effects of three poly-
saccharides on AI, and serum TC, LDL-C and VLDL-C
levels in the diabetic mice were significantly (P < 0.01 for
TC, LDL-C, VLDL-C, and AI) higher, while the HDL-C
levels were significantly (P < 0.01) lower than those in
the MC groups. After 2 weeks of gavage administration,
the contents of TC, LDL-C, and VLDL-C were de-
creased significantly and the contents of HDL-C were
increased significantly in the three dose groups than
those in the MC groups. Compared to the MC mice, the
TC, LDL-C, VLDL-C, and AI levels in group of En-
MZPS at 200 mg/Kg declined by 19.78 ± 1.42, 61.68 ±
1.33, 33.90 ± 5.47, and 79.85 ± 1.89 %, respectively. In the
mean time, the HDL-C increased by 45.45 ± 2.34 % at
the same dosage treatment.
Histopathological study of liver and kidney cortex
In the current study, histopathological observation of the
liver and kidney cortex were performed to corroborate the
evidence from biochemical analyses (Figs. 4 and 5).
As shown in Fig. 4, in comparison with the normal
cellular architecture of hepatic tissue of mice in the NC
group (Fig. 4a), extensive liver damage in diabetic mice
were observed after the injection of STZ characterized
by cellular degeneration, hepatocyte necrosis, and lipid
droplet accumulation (Fig. 4b). The pretreatment with
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Fig. 2 Effects of Ac-, Al, and En-MZPS on the activities of (A) SOD, (C) GSH-Px, (E) CAT, (G) MDA in liver and (B) SOD, (D) GSH-Px, (F) CAT, (H)
MDA in kidney in STZ-treated mice. The values are reported as the mean ± SD of ten mice per group: (a) P < 0.01 and (b) P < 0.05 compared with
NC groups; (c) P < 0.01, and (d) P < 0.05 compared with the MC groups
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Fig. 3 Effects of Ac-, Al, and En-MZPS on (A) ALT activities, (B) AST activities, (C) BUN levels, (D) CRE levels, (E) ALB levels, (F) AI levels and (G)
levels of TC, HDL-C, LDL-C, and VLDL-C in STZ-treated mice. The values are reported as the mean ± SD of ten mice per group: (a) P < 0.01 and
(b) P < 0.05 compared with NC groups; (c) P < 0.01, and (d) P < 0.05 compared with the MC groups
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Ac-, Al- and En-MZPS exhibited a marked improvement
in the liver histopathology evidenced by a diminution of
necrotic zones and attenuation of lipid droplet accumu-
lation against STZ-induced histological alteration
(Figs. 4d–l), especially En-MZPS at 200 mg/Kg, suggest-
ing that administration of low dosage of En-MZPS could
achieve almost complete normalization of the liver
tissues (Fig. 4l).
Figure 5 showed kidney cortex histology under light
microscopy. Renal tubules in mice of MC group
showed loss of brush border and integrity, vacuolation
of tubular epithelial cells and acute tubular necrosis
after STZ injection (Fig. 5b) as compared to thee NC
group with normal architecture (Fig. 5a). Interestingly,
these pathological changes were markedly attenuated
with the three tested polysaccharides (Figs. 5d–l),
especially using En-MZPS at low dosage (200 mg/kg)
(Fig. 5l).
Acute toxicity study
Mice (both males and females) administered Ac-, Al-,
and En-MZPS did not induce any clinical signs of
toxicity either immediately or during the post-
treatment period at dosage of 5000 mg/Kg, indicating
that Ac-, Al-, and En-MZPS were all practically non-
toxic substances [29].
Discussion
Diabetes mellitus (DM), characterized by hyperglycemia
and abnormalities in carbohydrate, lipid and protein me-
tabolism, was one of the most common human metabolic
diseases. And The STZ-induced diabetic animal is thus
considered as an animal model of type I diabetes and
hyperlipidemia [30]. The precise working mechanisms
about the anti-diabetic effects were still not fully under-
stood up till now [31, 32]. However, accumulating studies
had suggested that oxidative stress played a crucial role in
Fig. 4 Representative photomicrographs of liver histopathology (400×). a: liver in mice of NC groups showing normal cellular architecture of
hepatic tissue; (b): liver of mice in MC groups after injection of STZ (120 mg/Kg) showing cellular degeneration, hepatocyte necrosis, and lipid
droplet accumulation; (c): liver of mice in PC groups; (d-f): liver of mice fed with Ac-, Al-, and En-MZPS at dosage of 800 mg/Kg showing mild
architectural damage; (h-i): liver of mice fed with Ac-, Al-, and En-MZPS at dosage of 400 mg/Kg showing mild architectural damage with few
showing abnormal structure; (j-l): liver of mice fed with Ac-, Al-, and En-MZPS at dosage of 200 mg/Kg showing almost normal histology similar
to control mice
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the pathogenesis and progression of diabetes and its com-
plications [33]. Baynes et al. proved that uncontrolled
ROS production often led to damage in cellular macro-
molecules (DNA, lipids and proteins), contributing to the
progress of diabetic complications and different organ
damage [12]. The high toxicity of STZ engendered lipid
peroxidation and depletion of the antioxidant enzymes
and eventually liver damage. The present study reported
the antioxidative activities of three extractable mycelium
zinc polysaccharides (Ac-, Al- and En-MZPS) from P.
djamor on liver and kidney of normal and STZ-induced
diabetic mice using enzymatic and non-enzymatic
methods under in vivo conditions.
Liver and kidney, which were the sensitive organs with
chemotherapy cytotoxicity, played important roles in glu-
cose metabolism of diabetic animals [34]. The AST and
ALT activities in serum had been used as biochemical
markers for liver damage [35], and the enzyme activities
were markedly heightened when liver damaged occurred
[36]. It had been reported that the leakage of large quan-
tities of enzymes into the bloodstream was associated with
massive centrilobular necrosis, ballooning degeneration,
and cellular infiltration of the liver [37, 38]. This was con-
sistent with our results presented in Figs. 3A, B and 4b.
The other two parameters including BUN and CRE levels
had been widely used in clinical to reflect the physical
Fig. 5 Representative photomicrographs of kidney cortex histopathology (400×). a: kidney cortex of mice in NC groups showing normal
architecture; (b): kidney cortex of mice in MC groups after injection of STZ (120 mg/Kg) showing complete destruction of normal architecture of
kidney cortex including shrunken proximal renal tubular cells with chromatin condensation, cytoplasm with vacuolation and cells with swelling
and lysis; (c): kidney cortex of mice in PC groups; (d-f): kidney cortex of mice fed with Ac-, Al-, and En-MZPS at dosage of 800 mg/Kg showing
mild architectural damage; (g-i): kidney cortex of mice fed with Ac-, Al-, and En-MZPS at dosage of 400 mg/Kg showing mild architectural
damage with few showing abnormal structure; (j-l): kidney cortex of mice fed with Ac-, Al-, and En-MZPS at dosage of 200 mg/Kg showing
almost normal histology similar to control mice
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status of kidney [39]. The BUN, first endogenous sub-
stance produced by the decomposition of proteins in liver,
was excreted by the filtration of glomerulus. The CRE, a
byproduct of creatine and phosphocreatine catabol-
ism, was endogenously produced and released into
body fluids. And its clearance measured as an indica-
tor of glomerular filtration rate [40]. The suppression
of AST and ALT activities, BUN and CRE levels, as
well as ALB levels in serum brought about by Ac-,
Al- and En-MZPS indicated the stabilization of
plasma membrane as well as repair of hepatic and
nephritic tissue damages caused by STZ.
In addition, in order to understand the causal roles of
the antioxidant activities and protective effects of the
three polysaccharides on liver and kidney damage in-
duced by STZ, the activities of antioxidant enzymes
(SOD, GSH-Px and CAT) and the lipid contents (MDA)
in the liver and kidney homogenate were determined.
Antioxidant enzymes, converted active oxygen molecules
into non-toxic compounds, formed the first line of
defense against ROS in the organism during oxidative
stress [24]. Free radical scavenging enzymes including
SOD, GSH-Px and CAT were the first line of defense
against oxidative injury in mammalian systems [41]. The
role of SOD was to catalyze the superoxide anion into
hydrogen peroxide and oxygen and reduced the intracel-
lular concentration of superoxide [42]; CAT hold the
function that catalyzed the decomposition of hydrogen
peroxide into less-reactive gaseous oxygen and water
molecules [43]; The biochemical function of GSH-Px
was to catalyze lipid hydroperoxides to their correspond-
ing alcohols and to catalyze free hydrogen peroxide to
H2O [44], resulting in the prevention of ROS formation
[35, 45, 46]. Therefore, the statuses of these antioxidant
enzymes were appropriate indirect ways to assess the
pro-oxidant-antioxidant status in tissues [47]. In
addition, the ROS could interact with polyunsaturated
fatty acids, leading the formation of lipid peroxidation
(MDA), which was considered to be a hallmark of oxida-
tive stress causing tissue damages [45]. Lipid peroxide
was a primary parameter which could be considered as a
marker of oxidative injury in vivo [48]. Totally, in our
study, STZ injection caused the decrease in SOD, GSH-
Px, and CAT activities, and the increase in MDA
contents of mice as compared with the NC groups, sug-
gesting that oxidative damage occurred in the liver and
kidney. And the pretreatment with three polysaccharides
significantly reversed these deleterious changes. These
effects might, at least in part, be derived from the cap-
ability of MZPS to scavenge ROS.
Oral administration of polysaccharides from P. djamor
caused significantly lower GLU levels in STZ-induced
diabetic mice, similar to the findings of other fungal
polysaccharides [18, 20, 37]. Moreover, MZPS could
improve the loss of body weight in STZ-induced diabetic
mice, which may be attributed to the ability of MZPS to
significantly improve glucose homeostasis. In addition,
elevated TC, LDL-C, VLDL-C, and low HDL-C levels
were well established risk factors for coronary heart dis-
ease [49]. In this regard, MZPS administrations mark-
edly lowered TC, LDL-C, and VLDL-C levels, and
elevated the HDL-C levels in diabetic mice, suggesting
that MZPS had potential effects in improving hypergly-
cemia and hyperlipemia in STZ-induced diabetic mice.
Altogether, these findings suggested that the MZPS,
used in the present study, were novel bioactive com-
pounds responsible for the anti-diabetic effects, and thus
provided new insights into the anti-diabetic effects of
polysaccharides from P. djamor, as well as the potential
mechanisms. There were two possible reasons for
hypoglycemic effects of MZPS deduced from present
data. First, the MZPS could act as free radical scavengers
to quench ROS, possessing a direct anti-oxidative activ-
ity. Alternatively, MZPS could indirectly relieve the oxi-
dative damage of liver and kidney by improving the
antioxidant enzyme activities and reducing the lipid con-
tents, i.e., MZPS had potential effects in rescuing liver
functions in stabilizing the gluconeogenesis in the liver,
thus improving glucose metabolism in diabetic mice
(Fig. 2). Second, MZPS showed the inhibitory effects on
vascular inflammation, reflected by TC, HDL-C, LDL-C,
VLDL-C and AI levels from Figs. 3F and G, possibly
resulting in amelioration of inflammatory damage in
STZ-targeted tissues.
However, previous literatures had reported the poten-
tial relationships between lipid metabolism difference
and bacterial community change, indicating that the co-
lonic microflora played important biochemical activities
in regulating serum lipids and cholesterol by taking part
in metabolism [50]. Lots of intestinal bacteria, including
Bacteroides sp., Eubacterium sp., Butyrivibrio proteoclas-
ticus, Bifidobacterium bifidum, Lactobacillus fermentum,
and Lactobacillus reuteri, had been found increased in
mice colon after the intake of polysaccharides, suggest-
ing the potential effects of polysaccharides on the mice
lipid metabolism [51]. So, desiderated attentions should
be paid on the changed colon bacteria after the treat-
ment of these three polysaccharides, and there is a need
to continue to explore the relationship between free rad-
icals, diabetes, and its complications. And more studies
are needed to elucidate the mechanisms of action and
the efficacy of these three extractable zinc polysaccha-
rides administrations as an adjuvant therapy for diabetic
patients in an effort to expand treatment options.
Conclusions
From the results, we concluded that MZPS exerted pro-
tective effects in experimental diabetic mice induced by
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STZ injection, possibly by reducing oxidative stress of
liver and kidney, and hence, we asserted that MZPS had
potential effects in reducing the development of diabetic
complications. Above all, the results of this study may
provide a mechanistic basis for MZPS using as a poten-
tially natural and functional food for the prevention and
alleviation of diabetes and its complications.
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